✦ LIBER ✦

The genetic differences with whole genome linkage disequilibrium mapping between responder and non-responder in interferon-α and ribavirin combined therapy for chronic hepatitis C patients

✍ Scribed by P.-J. Chen; Y. Hwang; C. G.-J. Lin; Y.-J. Wu; L. S.-H. Wu

Book ID: 114831506
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 77 KB
Volume: 35
Category: Article
ISSN: 1744-3121
DOI: 10.1111/j.1744-313x.2008.00754.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early decrease of the viremia with ribav

Early decrease of the viremia with ribavirin and interferon combination therapy in patients with chronic hepatitis C non responders to the interferon

✍ P. Vega; M. Hermida; A. Castro; S.López Calvo; J. Baliñas; R. Torrón; JD. Pedrei 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Interferon alpha-2b and ribavirin in com

Interferon alpha-2b and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial

✍ Giuseppe Barbaro; Gabriella Di Lorenzo; Giancarlo Belloni; Luisella Ferrari; Ald 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Induction doses of interferon-α-2a in co

Induction doses of interferon-α-2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non-responders to interferon monotherapy: a randomized trial

✍ J. Salmerón; M. Diago; R. Andrade; R. Pérez; R. Solá; M. Romero; M. De La Mata; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

Comparison between IFNalpha2a + ribaviri

Comparison between IFNalpha2a + ribavirin and IFNalpha2a + amantadine combination therapy in naive patients with chronic hepatitis C-genotype 1, and between amantadine and ribavirin addition in non responders after 3 months

✍ Antonio Bellobuono; R. Finazzi; G. Covini; L. Milazzo; C. Magni; A.M. Milella; C 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Randomized trial of high-dose interferon

Randomized trial of high-dose interferon-α-2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy

✍ Nami Mori; Michio Imamura; Yoshiiku Kawakami; Hiromi Saneto; Tomokazu Kawaoka; S 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB 👁 1 views

## Abstract The aim of this study was to compare the efficacy of high‐dose interferon (IFN)‐α‐2b with standard dose of IFN‐α‐2b in combination with ribavirin (RBV) for patients with chronic hepatitis C virus (HCV) infection, and to investigate the predictive factors associated with virological resp